|
|
Article: Reportlinker Adds Therapeutic Monoclonal Antibodies Markets.
- Article from:
- Business Wire
- Article date:
- June 3, 2009
CopyrightCOPYRIGHT 2009 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
NEW YORK -- Reportlinker.com announces that a new market research report is available in its catalogue.
Reportlinker Adds Therapeutic Monoclonal Antibodies Markets
http://www.reportlinker.com/p0120329/Reportlinker-Adds-Therapeutic-Monoclonal-Antibodies-Markets.html
Antibodies are proteins in the immune system that help the body defend against foreign invasion, particularly from pathogens and toxins. As such, a human-engineered therapeutic monoclonal antibody (mAb) is protein derived from the immune system through recombinant DNA technology that has the ability to combine specifically with a target protein that plays a role in a disease process. ...